Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF injectable for scar prevention after bilateral breast reduction
NL-OMON47353Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial of autologous adipose stromal vascular fraction in Hypertrophic Scar (HS) (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Patient-reported scar assessment by POSAS. Started May 2016; status: active, not recruiting.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NL-OMON47353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47353.